Segment Information (Tables)

9 Months Ended

Sep. 27, 2024

Segment Reporting [Abstract]

Revenue, Gross Profit, Gross Profit Margin, Operating Income (Loss), and Depreciation and Amortization Expenses by Reportable Segment

Revenue, gross profit, gross profit margin, operating income (loss), and depreciation and amortization expenses by reportable segment were as follows (in thousands, except percentage data):

	Three Months Ended				Nine Months Ended
	September 27,		September 29,		September 27,		September 29,
Revenue	2024		2023		2024		2023
Precision Medicine and Manufacturing	$	60,595	$	71,277	$	189,781	$	215,138
Medical Solutions		103,783		83,378		310,760		244,340
Robotics and Automation		80,027		66,848		210,644		210,615
Total	$	244,405	$	221,503	$	711,185	$	670,093

	Three Months Ended						Nine Months Ended
	September 27,			September 29,			September 27,			September 29,
Gross Profit	2024			2023			2024			2023
Precision Medicine and Manufacturing	$	27,048		$	36,208		$	89,412		$	107,054
Medical Solutions		42,373			34,027			122,128			100,170
Robotics and Automation		40,569			32,652			104,506			100,376
Unallocated Corporate and Shared Services		(775	)		(1,296	)		(2,726	)		(4,258	)
Total	$	109,215		$	101,591		$	313,320		$	303,342

	Three Months Ended						Nine Months Ended
	September 27,			September 29,			September 27,			September 29,
Gross Profit Margin	2024			2023			2024			2023
Precision Medicine and Manufacturing		44.6	%		50.8	%		47.1	%		49.8	%
Medical Solutions		40.8	%		40.8	%		39.3	%		41.0	%
Robotics and Automation		50.7	%		48.8	%		49.6	%		47.7	%
Total		44.7	%		45.9	%		44.1	%		45.3	%

	Three Months Ended						Nine Months Ended
	September 27,			September 29,			September 27,			September 29,
Operating Income (Loss)	2024			2023			2024			2023
Precision Medicine and Manufacturing	$	11,879		$	18,508		$	40,367		$	54,803
Medical Solutions		12,421			11,050			36,686			30,974
Robotics and Automation		22,086			12,208			48,950			39,456
Unallocated Corporate and Shared Services		(13,831	)		(11,457	)		(42,126	)		(36,414	)
Total	$	32,555		$	30,309		$	83,877		$	88,819

	Three Months Ended				Nine Months Ended
	September 27,		September 29,		September 27,		September 29,
Depreciation and Amortization Expenses	2024		2023		2024		2023
Precision Medicine and Manufacturing	$	2,806	$	2,644	$	7,621	$	7,901
Medical Solutions		6,891		3,860		20,216		11,877
Robotics and Automation		4,015		4,705		12,010		14,467
Unallocated Corporate and Shared Services		443		188		1,353		820
Total	$	14,155	$	11,397	$	41,200	$	35,065

Schedule of Geographic Revenue

The Company aggregates geographic revenue based on the customer locations where products are shipped to. Revenue by geography was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	September 27,		September 29,		September 27,		September 29,
	2024		2023		2024		2023
United States	$	124,328	$	110,462	$	364,800	$	321,898
Germany		33,559		33,263		98,659		100,222
Rest of Europe		30,584		34,257		94,083		98,159
China		24,623		15,679		60,708		54,331
Rest of Asia-Pacific		27,147		24,060		79,737		79,561
Other		4,164		3,782		13,198		15,922
Total	$	244,405	$	221,503	$	711,185	$	670,093

Revenue By End Market

The Company primarily operates in two end markets: the medical market and the advanced industrial market. Revenue by end market was approximately as follows:

	Three Months Ended						Nine Months Ended
	September 27,			September 29,			September 27,			September 29,
	2024			2023			2024			2023
Medical		54	%		57	%		56	%		54	%
Advanced Industrial		46	%		43	%		44	%		46	%
Total		100	%		100	%		100	%		100	%